Takeda Pharmaceutical CoTSE:4502 +1.61%65 Days Payable is 89.06 as of Mar. 2026, which is 6% above its 10-year median of 84.25. GuruFocus rates TSE:4502 with a GF Score™ of 65/100 and a GF Value™ of 円4,534.12 (Modestly Overvalued). The stock has 8 warning signs investors should review. Among 922 Drug Manufacturers companies, Takeda Pharmaceutical Co ranks better than 50.22% on this metric.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Takeda Pharmaceutical Co's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Takeda Pharmaceutical Co Days Payable vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Takeda Pharmaceutical Co's Days Payable distribution charts can be found below:
* The bar in red indicates where Takeda Pharmaceutical Co's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Takeda Pharmaceutical Co's Days Payable for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Takeda Pharmaceutical Co (TSE:4502) has a Days Payable of 89.06 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Takeda Pharmaceutical Co and its competitors. This is near median its historical median of 84.25. Over the past decade, Takeda Pharmaceutical Co's Days Payable has ranged from 71.00 to 141.01. According to the industry distribution chart, Takeda Pharmaceutical Co ranks #459 out of 922 companies in the Drug Manufacturers industry, placing it in the top 49.8%.
Is Takeda Pharmaceutical Co's Days Payable too high?
Takeda Pharmaceutical Co's current Days Payable of 89.06 is near median its 10-year median of 84.25. Over the past 10 years, this metric has ranged from a low of 71.00 to a high of 141.01. The Drug Manufacturers industry median Days Payable is 90.84. Takeda Pharmaceutical Co's value of 89.06 is 2% below this industry median. Based on the distribution chart, Takeda Pharmaceutical Co ranks #459 out of 922 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Takeda Pharmaceutical Co has a GF Score™ of 65/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Takeda Pharmaceutical Co's Days Payable compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Takeda Pharmaceutical Co ranks #459 out of 922 companies for Days Payable. This puts Takeda Pharmaceutical Co in the upper half of its industry. The industry median Days Payable is 90.84. Takeda Pharmaceutical Co's value of 89.06 is 2% below this benchmark. Historically, Takeda Pharmaceutical Co's own Days Payable has ranged from 71.00 to 141.01 over the past decade. While the company's 10-year median is 84.25 vs. the industry median of 90.84, Takeda Pharmaceutical Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Drug Manufacturers company?
The median Days Payable among Drug Manufacturers companies is 90.84, based on 922 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Takeda Pharmaceutical Co's current Days Payable of 89.06 is 2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Takeda Pharmaceutical Co and its competitors. For the Drug Manufacturers industry, the median Days Payable is 90.84 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Takeda Pharmaceutical Co's current Days Payable is 89.06, which is near median its own 10-year median of 84.25. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Takeda Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Takeda Pharmaceutical Co (TSE:4502) is currently considered Modestly Overvalued. The stock's GF Value™ is 円4,534.12, compared to a current price of 円5,359.00 — trading 18.2% above its estimated fair value. The current Days Payable is 89.06, which is near median its 10-year median of 84.25 and 2% below the Drug Manufacturers industry median of 90.84. Takeda Pharmaceutical Co's overall GF Score™ is 65/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Takeda Pharmaceutical Co (TSE:4502), the current Days Payable is 89.06 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Takeda Pharmaceutical Co (TSE:4502) Overvalued in 2026?
Based on GuruFocus' analysis, Takeda Pharmaceutical Co stock appears to be overvalued.
The current stock price of 円5,359.00 is trading 18.2% above its estimated GF Value™ of 円4,534.12.
GuruFocus considers Takeda Pharmaceutical Co to be Modestly Overvalued.
Key valuation signals for TSE:4502:
Days Payable: 89.06 (near median its 10-year median of 84.25)
GF Value™: 円4,534.12 vs. price of 円5,359.00 (18.2% above fair value)
Industry Position: 2% below the Drug Manufacturers median (#459 of 922)
No single metric tells the full story. See the TSE:4502 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.5 trillion in fiscal 2025. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with about 50% from the US, 10% from Japan, 25% from Europe, and 15% from Canada.
65GF Score
Get the complete analysis for TSE:4502
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:4502 has been successfully added to your 
